Cargando…
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
BACKGROUND: Non-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We describe the prevalence of NTM and Mycobacterium...
Autores principales: | Agizew, Tefera, Basotli, Joyce, Alexander, Heather, Boyd, Rosanna, Letsibogo, Gaoraelwe, Auld, Andrew, Nyirenda, Sambayawo, Tedla, Zegabriel, Mathoma, Anikie, Mathebula, Unami, Pals, Sherri, Date, Anand, Finlay, Alyssa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741233/ https://www.ncbi.nlm.nih.gov/pubmed/29272273 http://dx.doi.org/10.1371/journal.pone.0189981 |
Ejemplares similares
-
Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana
por: Agizew, Tefera, et al.
Publicado: (2017) -
Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial
por: Agizew, Tefera, et al.
Publicado: (2019) -
The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear
por: Zimba, Onani, et al.
Publicado: (2019) -
Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana’s Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality
por: Auld, Andrew F., et al.
Publicado: (2016) -
Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria
por: Agizew, Tefera, et al.
Publicado: (2020)